ReWalk Robotics to Discuss 2015 First Quarter Financial Results on May 7, 2015 Conference Call
GlobeNewswire - Thu Apr 23, 3:30PM CDT
ReWalk Robotics Ltd. (Nasdaq:RWLK) will release its 2015 first quarter financial results on Thursday, May 7, 2015, before the U.S. financial markets open.
RWLK: 12.80 (-0.03)
ReWalk Robotics: Board Member Resignations Are Concerning
Dallas Salazar - at Seeking Alpha - Mon Apr 20, 12:47PM CDT
RWLK: 12.80 (-0.03)
ReWalk Robotics (RWLK) Jumps: Stock Rises 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 8:11AM CDT
ReWalk Robotics Ltd. (RWLK) was a big mover last session, as the company saw its shares rise roughly 10% on the day.
INGN: 37.13 (+0.11), RWLK: 12.80 (-0.03)
Second Sight Medical Sees 'Major Milestone'
at Investor's Business Daily - Wed Apr 08, 3:11PM CDT
Shares of Second Sight Medical Products (EYES) jumped Wednesday as the maker of implantable visual prosthetics reported successful test results in an animal study. Second Sight announced the first successful test of a mechanical model of its Orion I...
EYES: 13.35 (-0.35), RWLK: 12.80 (-0.03)
Ekso Bionics' Rehab Vertical Gets Healthy With Some Big News From The U.K.
Dallas Salazar - at Seeking Alpha - Mon Apr 06, 6:55AM CDT
RWLK: 12.80 (-0.03)
ReWalk Robotics: Immense Potential In Underserved Market
Simple Investment Ideas - at Seeking Alpha - Fri Mar 20, 1:59PM CDT
RWLK: 12.80 (-0.03)
IPO Lockup Expiration: ReWalk Robotics Ltd.
Don Dion - at Seeking Alpha - Tue Mar 03, 7:18AM CST
PH: 122.49 (-0.94), RWLK: 12.80 (-0.03)
ReWalk CEO Discusses the Company's IPO and How it is Helping Paraplegics Walk
at The Street - Thu Feb 19, 3:16PM CST
The maker of exoskeletons for paraplegics went public on the NASDAQ late last year, and though shares have tumbled, the CEO is confident in the company's growth.
PH: 122.49 (-0.94), RWLK: 12.80 (-0.03), SANM: 20.81 (-0.03)
5 Stocks Poised for Breakouts: SunEdison, Moneygram and More
at The Street - Fri Feb 13, 7:29AM CST
These stocks look ready to break out and trade higher from current levels.
MGI: 8.12 (-0.06), RCAP: 8.40 (-0.44), SUNE: 26.61 (-0.89), SXE: 15.86 (+0.28), RWLK: 12.80 (-0.03)
ReWalk Robotics Has Been One Painful Science Experiment For Investors
Dallas Salazar - at Seeking Alpha - Thu Feb 12, 11:09PM CST
RWLK: 12.80 (-0.03)
ReWalk ups revenues 275% in Q4
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 9:42AM CST
RWLK: 12.80 (-0.03)
ReWalK Net Loss of $4.63M
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 6:25AM CST
RWLK: 12.80 (-0.03)
ReWalk Robotics Reports Fourth Quarter and Year-End 2014 Financial Results
GlobeNewswire - Thu Feb 12, 6:16AM CST
ReWalk Robotics Ltd. (Nasdaq:RWLK) ("ReWalk," or "the Company"
RWLK: 12.80 (-0.03)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 4:30PM CST
NLSN: 45.95 (-0.36), RTIX: 5.86 (+0.09), AAP: 148.61 (+1.92), JAH: 52.23 (-0.97), LMNS: 11.51 (+0.24), THS: 85.06 (+0.19), RWLK: 12.80 (-0.03), CAB: 54.19 (-3.13), FAF: 37.83 (+0.76), HSP: 87.61 (-0.05), PNK: 36.73 (+0.45), MFA: 7.96 (unch), SPW: 82.18 (-0.80), MFC: 18.43 (+0.12), HIMX: 6.22 (-0.04), LNCE: 30.94 (+0.04), TIME: 22.56 (-0.35), AVP: 9.02 (+0.03), INCY: 107.34 (-0.51), NNN: 41.04 (-0.13), NWE: 53.12 (+0.40), COR: 50.35 (+0.52), MHFI: 106.23 (+0.97), NCI: 14.27 (-0.01), BWA: 60.79 (+0.10), HERO: 0.71 (+0.02), NRP: 5.26 (-0.57), STC: 38.75 (-0.03), AB: 31.69 (-0.05), CPLA: 66.65 (-1.23), TU: 35.16 (-0.03), IFF: 115.85 (-0.72), GNC: 47.17 (+0.30), MINI: 41.98 (-0.17), ACOR: 33.12 (-0.38), CVE: 19.16 (-0.11), SNI: 69.91 (-0.29), CCE: 45.40 (+0.29), K: 63.73 (-0.12), DPS: 78.86 (-0.09), BG: 85.80 (+0.09), AAWW: 43.06 (-0.23), Q: 69.09 (+1.40), SHPG: 255.11 (-0.26), MANU: 15.79 (unch), MPEL: 21.99 (+0.07), APA: 66.32 (-2.03), DBD: 35.14 (-0.34), MPW: 14.67 (+0.07), HE: 32.36 (+0.14), RYN: 26.12 (-0.06), CS: 26.16 (-0.48), PDS: 6.85 (-0.07), ANR: 0.83 (unch), SON: 44.79 (+0.27), SKYW: 14.04 (+0.23), LPNT: 77.91 (+0.16), RDN: 18.37 (-0.08), MDWD: 6.73 (-0.28), SCOR: 53.48 (+0.13), FLO: 22.31 (-0.20)
Research and Markets: Global Exoskeleton System Market 2015-2019: Key Vendors are Cyberdyne, Ekso Bionics, ReWalk Robotics & Rex Bionics
Business Wire - Wed Feb 11, 3:01PM CST
Research and Markets (http://www.researchandmarkets.com/research/rh4pd7/global) has announced the addition of the "Global Exoskeleton System Market 2015-2019" report to their offering.
RWLK: 12.80 (-0.03)
Global Exoskeleton System Market 2015-2019: Key Vendors are Cyberdyne, Ekso Bionics, ReWalk Robotics & Rex Bionics
M2 - Wed Feb 11, 2:32PM CST
Research and Markets (http://www.researchandmarkets.com/research/5n9pd6/global) has announced the addition of the "Global Exoskeleton System Market 2015-2019" report to their offering. The Global Exoskeleton System market to grow at a CAGR of 72.51% over the period 2014-2019 An exoskeleton system is a man-machine system that combines human intelligence and machine power, thereby enabling individuals to gain super strength to walk or move. It is widely used across the Healthcare sector for rehabilitation. In rehabilitation centers, an exoskeleton system helps in tendon therapy and exercise. Individuals suffering from hip or knee conditions can use exoskeleton system to prevent common accidents such as slipping or to walk again. These systems are also used across the Military and Industrial sectors. One of the major trends in the market is the development of an exoskeleton-mounted computer system for soldiers. The US military has awarded several exoskeleton R&D project contracts to various robotic companies and research institutes in the Americas. According to the report, the rise in orthopedic disorders is a major growth driver for the market. The use of exoskeletons by people with orthopedic disorders helps improve their mobility because they put the body in an upright position, thereby bringing back their self-esteem. Further, the report states that one of the major challenges that the market faces is the high price of exoskeleton systems, which means that they are not affordable for many paralyzed individuals in the developing countries. Several paralyzed individuals in the developing countries cannot afford to buy exoskeletons because insurance companies do not provide funds to buy such devices. Key Vendors - Cyberdyne - Ekso Bionics - ReWalk Robotics - Rex Bionics Other Prominent Vendors - Berkley Robotics - Focal Meditech - Hocoma - Honda - Interactive Motion Technologies - LockHeed Martin - Myomo - Parker Hannafin - Raytheon Sarcos For more information visit http://www.researchandmarkets.com/research/5n9pd6/global
RTN: 108.35 (-0.20), RWLK: 12.80 (-0.03)
Global Exoskeleton System Market 2015-2019 with Cyberdyne, Ekso Bionics, ReWalk Robotics & Rex Bionics Dominating
PR Newswire Europe - Wed Feb 11, 12:32PM CST
DUBLIN, Feb .11, 2015 /PRNewswire/ --Research and Markets
RWLK: 12.80 (-0.03)
ReWalk Robotics to Discuss Fourth Quarter and Year-End 2014 Financial Results on February 12, 2015 Conference Call
GlobeNewswire - Mon Feb 02, 9:06AM CST
ReWalk Robotics Ltd. (Nasdaq:RWLK) will release its 2014 fourth quarter and year-end financial results on Thursday, February 12, 2015, before the U.S. financial markets open.
RWLK: 12.80 (-0.03)
ReWalk reports February 12
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 7:55AM CST
RWLK: 12.80 (-0.03)